Drugs, Medical Devices & Laboratory Tools

Own the manufacturers behind healthcare delivery: medical devices, diagnostic systems, laboratory equipment and commercial medicines, rather than insurers or speculative discovery platforms. Danaher's latest results provide a timely checkpoint for laboratory and bioprocessing demand while the market questions AI spending. The basket emphasizes devices and tools, with established medicine manufacturers broadening its product exposure; hospital budgets, research spending and drug competition remain risks. Catalysts: - 2026-10-21 DHR: Danaher reports third-quarter 2026 results (https://www.stocktitan.net/news/2026-10-21/) Launch basket (equal weight): MDT, JNJ, TMO, ABBV, AMGN, DHR, ABT, SYK, BSX, GEHC Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.